Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 1
2007 2
2009 1
2012 1
2013 1
2014 6
2015 20
2016 50
2017 70
2018 97
2019 110
2020 170
2021 207
2022 187
2023 134

Text availability

Article attribute

Article type

Publication date

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
Neural modulation for hypertension and heart failure.
Smith S, Rossignol P, Willis S, Zannad F, Mentz R, Pocock S, Bisognano J, Nadim Y, Geller N, Ruble S, Linde C. Smith S, et al. Int J Cardiol. 2016 Jul 1;214:320-30. doi: 10.1016/j.ijcard.2016.03.078. Epub 2016 Apr 4. Int J Cardiol. 2016. PMID: 27085120 Review.
Therefore, the potential role of neuromodulation via renal denervation, baro-reflex modulation and vagal stimulation for the treatment of resistant HTN and HF is being explored. ...We describe lessons learned from recent neuromodulation trials and outline strategies to imp …
Therefore, the potential role of neuromodulation via renal denervation, baro-reflex modulation and vagal stimulation for the treatmen …
Heart Failure Clinical Trials in East and Southeast Asia: Understanding the Importance and Defining the Next Steps.
Mentz RJ, Roessig L, Greenberg BH, Sato N, Shinagawa K, Yeo D, Kwok BW, Reyes EB, Krum H, Pieske B, Greene SJ, Ambrosy AP, Kelly JP, Zannad F, Pitt B, Lam CS. Mentz RJ, et al. JACC Heart Fail. 2016 Jun;4(6):419-27. doi: 10.1016/j.jchf.2016.01.013. JACC Heart Fail. 2016. PMID: 27256745 Free PMC article. Review.
Representation of Asians in landmark HF trials has been variable. In addition, HF patients from Asia demonstrate clinical differences from patients in other geographic regions. Thus, the generalizability of some clinical trial results to the Asian population remains …
Representation of Asians in landmark HF trials has been variable. In addition, HF patients from Asia demonstrate clinical differences …
The safety of mineralocorticoid receptor antagonists (MRAs) in patients with heart failure.
Pitt B, Rossignol P. Pitt B, et al. Expert Opin Drug Saf. 2016 May;15(5):659-65. doi: 10.1517/14740338.2016.1163335. Epub 2016 Apr 11. Expert Opin Drug Saf. 2016. PMID: 26958701 Review.
Uptake, however, has been less than optimal largely due to concerns about their safety, in particular the risk of hyperkalemia and renal dysfunction. AREAS COVERED: This review presents the current state of affairs regarding the safety of MRAs in heart failure with reduced …
Uptake, however, has been less than optimal largely due to concerns about their safety, in particular the risk of hyperkalemia and renal …
Emergency management of severe hyperkalemia: Guideline for best practice and opportunities for the future.
Rossignol P, Legrand M, Kosiborod M, Hollenberg SM, Peacock WF, Emmett M, Epstein M, Kovesdy CP, Yilmaz MB, Stough WG, Gayat E, Pitt B, Zannad F, Mebazaa A. Rossignol P, et al. Pharmacol Res. 2016 Nov;113(Pt A):585-591. doi: 10.1016/j.phrs.2016.09.039. Epub 2016 Sep 29. Pharmacol Res. 2016. PMID: 27693804 Review.
Determining whether emergency therapy is warranted is largely based on subjective clinical judgment. The Investigator Network Initiative Cardiovascular and Renal Clinical Trialists (INI-CRCT) aimed to evaluate …
Determining whether emergency therapy is warranted is largely based on subjective clinical judgment. The Investigator Netwo …
Clinical management of the uraemic syndrome in chronic kidney disease.
Vanholder R, Fouque D, Glorieux G, Heine GH, Kanbay M, Mallamaci F, Massy ZA, Ortiz A, Rossignol P, Wiecek A, Zoccali C, London GM; European Renal Association European Dialysis; Transplant Association (ERA-EDTA) European Renal; Cardiovascular Medicine (EURECA-m) working group. Vanholder R, et al. Lancet Diabetes Endocrinol. 2016 Apr;4(4):360-73. doi: 10.1016/S2213-8587(16)00033-4. Epub 2016 Mar 3. Lancet Diabetes Endocrinol. 2016. PMID: 26948372 Review.
The clinical picture of the uraemic syndrome is a complex amalgam of accelerated ageing and organ dysfunction, which progress in parallel to chronic kidney disease. The uraemic syndrome is associated with cardiovascular disease, metabolic bone disease, inflammation, …
The clinical picture of the uraemic syndrome is a complex amalgam of accelerated ageing and organ dysfunction, which progress in para …
The CKD Outcomes and Practice Patterns Study (CKDopps): Rationale and Methods.
Mariani L, Stengel B, Combe C, Massy ZA, Reichel H, Fliser D, Pecoits-Filho R, Lopes AA, Yamagata K, Wada T, Wong MM, Speyer E, Port FK, Pisoni RL, Robinson BM. Mariani L, et al. Am J Kidney Dis. 2016 Sep;68(3):402-13. doi: 10.1053/j.ajkd.2016.03.414. Epub 2016 Apr 22. Am J Kidney Dis. 2016. PMID: 27113505
LIMITATIONS: CKDopps does not capture care provided in settings outside nephrology clinics (eg, primary care) or patients with CKD not receiving medical care. ...CKDopps aims to establish a multinational infrastructure for research, colla …
LIMITATIONS: CKDopps does not capture care provided in settings outside nephrology clinics (eg, primary care) or patien …
Renal function estimation and Cockroft-Gault formulas for predicting cardiovascular mortality in population-based, cardiovascular risk, heart failure and post-myocardial infarction cohorts: The Heart 'OMics' in AGEing (HOMAGE) and the high-risk myocardial infarction database initiatives.
Ferreira JP, Girerd N, Pellicori P, Duarte K, Girerd S, Pfeffer MA, McMurray JJ, Pitt B, Dickstein K, Jacobs L, Staessen JA, Butler J, Latini R, Masson S, Mebazaa A, Rocca HP, Delles C, Heymans S, Sattar N, Jukema JW, Cleland JG, Zannad F, Rossignol P; Heart ‘OMics’ in AGEing (HOMAGE) initiative and the High-Risk Myocardial Infarction database initiative. Ferreira JP, et al. BMC Med. 2016 Nov 10;14(1):181. doi: 10.1186/s12916-016-0731-2. BMC Med. 2016. PMID: 27829460 Free PMC article. Clinical Trial.
BACKGROUND: Renal impairment is a major risk factor for mortality in various populations. ...METHODS: Two previously published cohorts of pooled patient data derived from the partners involved in the HOMAGE-consortium and from four clinical trials - CAPRICORN, EPHES …
BACKGROUND: Renal impairment is a major risk factor for mortality in various populations. ...METHODS: Two previously published cohort …
Natriuretic Peptides, 6-Min Walk Test, and Quality-of-Life Questionnaires as Clinically Meaningful Endpoints in HF Trials.
Ferreira JP, Duarte K, Graves TL, Zile MR, Abraham WT, Weaver FA, Lindenfeld J, Zannad F. Ferreira JP, et al. J Am Coll Cardiol. 2016 Dec 20;68(24):2690-2707. doi: 10.1016/j.jacc.2016.09.936. J Am Coll Cardiol. 2016. PMID: 27978953 Free article. Review.
The Food and Drug Administration would consider assessments of a device's effect on intermediate endpoints that, when improving in a congruent fashion, are reasonably likely to predict clinical benefit. ...
The Food and Drug Administration would consider assessments of a device's effect on intermediate endpoints that, when improving in a …
NT-proBNP and Echocardiographic Parameters for Prediction of Cardiovascular Outcomes in Patients with CKD Stages G2-G4.
Untersteller K, Girerd N, Duarte K, Rogacev KS, Seiler-Mussler S, Fliser D, Rossignol P, Heine GH. Untersteller K, et al. Clin J Am Soc Nephrol. 2016 Nov 7;11(11):1978-1988. doi: 10.2215/CJN.01660216. Epub 2016 Aug 11. Clin J Am Soc Nephrol. 2016. PMID: 27515593 Free PMC article.
We aimed to analyze the implications of using NT-proBNP alone, echocardiographic parameters alone, or a combination of both for prediction of adverse cardiovascular outcome. DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: Within the longitudinal Cardiovascular an …
We aimed to analyze the implications of using NT-proBNP alone, echocardiographic parameters alone, or a combination of both for prediction o …
Antithrombotic therapy in heart failure patients with and without atrial fibrillation: update and future challenges.
Ferreira JP, Girerd N, Alshalash S, Konstam MA, Zannad F. Ferreira JP, et al. Eur Heart J. 2016 Aug;37(31):2455-64. doi: 10.1093/eurheartj/ehw213. Epub 2016 Jun 1. Eur Heart J. 2016. PMID: 27252452 Review.
In patients with HF and sinus rhythm, the risk of stroke and other thrombotic events is high, and the use of warfarin has not, to date, been shown to confer outcome benefit. The benefit of the NOAC, rivaroxaban, is being investigated in HF without AF in the ongoing COMMAND …
In patients with HF and sinus rhythm, the risk of stroke and other thrombotic events is high, and the use of warfarin has not, to date, been …
50 results